Announcement of the Completion of Stage I and the Start of Enrollment for Stage II of the Phase I/II Clinical Trial of Genetically Recombinant Human Serum Albumin (Code:Â RU-101) Ophthalmic Solution for the Treatment of Seve<4573.T>